Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users.

Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Abstract Text:

Evan Wood,Thomas Kerr,Mark W Tyndall,Ruth Zhang,Robert S Hogg,Steffanie A Strathdee,Julio S G Montaner,Evan Wood,Thomas Kerr,Mark W Tyndall,Ruth Zhang,Robert S Hogg,Steffanie A Strathdee,Julio S G Montaner,

Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Publishing Authors By Initials

E Wood,T Kerr,MW Tyndall,R Zhang,RS Hogg,SA Strathdee,JS Montaner,E Wood,T Kerr,MW Tyndall,R Zhang,RS Hogg,SA Strathdee,JS Montaner,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Addiction (Abingdon, England)

VOLUME: 102

Page Numbers: 1503-5

Journal Abbreviation: Addiction

ISSN: 0965-2140

DAY: 16

MONTH: Sep

YEAR: 2007

Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9304118

Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users.

AFFILIATION:

Country: England

AGENCY: United States NIDA

GRANT: R01 DA011591-04A1

ACRONYM: DA

MEDLINETA: Addiction

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users Related Publications

• A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administration.
• A review of barriers and facilitators of HIV treatment among injection drug users.
• Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
• Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.
• Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator related hemorrhagic transformation.
• Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes.
• Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.
• Ethical and scientific issues surrounding solid organ transplantation in HIV-positive patients: Absence of evidence is not evidence of absence.
• Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage.
• Genetics of stroke: a review of recent advances.
• Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
• Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users.
• Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption
• Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
• MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.
• Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006.
• Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases.
• NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells.
• Outcomes of multidrug-resistant patients switched from enfuvirtide to raltegravir within a virologically suppressive regimen.
• Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis.
• Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users.
• Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?
• Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
• The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.
• The use of highly active retroviral therapy to reduce HIV incidence at the population level.
• Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.
• Transmission of drug-resistant HIV-1 from an infected individual to a caregiver.
• [Biological markers in spontaneous intracerebral hemorrhage]
• [Commentary] ANTIRETROVIRAL THERAPY: A KEY PART OF THE PUBLIC HEALTH RESPONSE TO INJECTION DRUG USE.
• [The therapeutic potential of endothelial progenitor cells in ischaemic stroke.]